Research and Development


Viscogel AB has developed a novel medical chitosan – Viscosan™- with unique properties providing the basis for two novel innovative soft particulate hydrogel drug delivery systems - Viscogel™ and Viscomulsion™ - for versatile, time-controlled delivery of biologics and small molecules. Viscogel’s proprietary technologies solve key obstacles to in vivo applications by providing a unique solution to the solubility problem and enabling controlled design.

ViscoGel™ has already been shown to be safe and well tolerated in a clinical trial.